Ruth Oratz

2.4k total citations
78 papers, 1.9k citations indexed

About

Ruth Oratz is a scholar working on Oncology, Molecular Biology and Immunology. According to data from OpenAlex, Ruth Oratz has authored 78 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Oncology, 27 papers in Molecular Biology and 27 papers in Immunology. Recurrent topics in Ruth Oratz's work include Immunotherapy and Immune Responses (24 papers), vaccines and immunoinformatics approaches (15 papers) and Cancer Immunotherapy and Biomarkers (13 papers). Ruth Oratz is often cited by papers focused on Immunotherapy and Immune Responses (24 papers), vaccines and immunoinformatics approaches (15 papers) and Cancer Immunotherapy and Biomarkers (13 papers). Ruth Oratz collaborates with scholars based in United States, Germany and Canada. Ruth Oratz's co-authors include Richard L. Shapiro, Franco M. Muggia, Jean‐Claude Bystryn, Daniel F. Roses, James L. Speyer, W. Fraser Symmans, Silvia C. Formenti, Herman Yee, Sandra Demaria and Abraham Chachoua and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and The Journal of Immunology.

In The Last Decade

Ruth Oratz

74 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ruth Oratz United States 24 1.2k 759 708 299 190 78 1.9k
Masahiro Kashiwaba Japan 16 877 0.8× 972 1.3× 642 0.9× 236 0.8× 166 0.9× 46 1.7k
Christina Coughlin United States 21 839 0.7× 922 1.2× 682 1.0× 152 0.5× 256 1.3× 34 1.8k
Ellen Chuang United States 24 1.3k 1.2× 1.7k 2.2× 882 1.2× 245 0.8× 188 1.0× 38 3.0k
Mark R. Albertini United States 28 1.2k 1.1× 1.1k 1.5× 1.0k 1.4× 225 0.8× 225 1.2× 97 2.4k
Dario Sangiolo Italy 25 1.4k 1.2× 1.1k 1.4× 549 0.8× 200 0.7× 442 2.3× 76 2.2k
Danny N. Khalil United States 14 950 0.8× 637 0.8× 410 0.6× 204 0.7× 274 1.4× 40 1.6k
Gheath Alatrash United States 24 1.8k 1.6× 1.3k 1.7× 674 1.0× 361 1.2× 385 2.0× 126 2.9k
Cara Haymaker United States 27 1.6k 1.4× 1.4k 1.8× 605 0.9× 246 0.8× 313 1.6× 130 2.5k
Christoph Höeller Austria 27 1.6k 1.4× 820 1.1× 1.0k 1.4× 149 0.5× 236 1.2× 73 2.5k
S A Cannistra United States 11 644 0.6× 502 0.7× 816 1.2× 402 1.3× 149 0.8× 11 2.4k

Countries citing papers authored by Ruth Oratz

Since Specialization
Citations

This map shows the geographic impact of Ruth Oratz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ruth Oratz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ruth Oratz more than expected).

Fields of papers citing papers by Ruth Oratz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ruth Oratz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ruth Oratz. The network helps show where Ruth Oratz may publish in the future.

Co-authorship network of co-authors of Ruth Oratz

This figure shows the co-authorship network connecting the top 25 collaborators of Ruth Oratz. A scholar is included among the top collaborators of Ruth Oratz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ruth Oratz. Ruth Oratz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Novik, Yelena, Adrian A. Franke, Karina Martínez‐Flores, et al.. (2025). Evaluation of the gut microbiome and sex hormones in postmenopausal women with newly diagnosed hormone receptor-positive breast cancer versus healthy women: a prospective case-control study. Journal of Cancer Research and Clinical Oncology. 151(10). 275–275. 1 indexed citations
2.
Schwartz, Daniella M., et al.. (2025). Misleading Allegations and Failure to Recognize the Shifting Faces of Antisemitism: A Response to J.J. Amon. Journal of Religion and Health. 65(1). 480–501.
3.
Schwartz, Daniella M., et al.. (2024). Social Media, Survey, and Medical Literature Data Reveal Escalating Antisemitism Within the United States Healthcare Community. Journal of Religion and Health. 64(1). 206–223. 2 indexed citations
4.
Adams, Sylvia, Ying Meng, Zane Schnurman, et al.. (2024). Improved outcomes for triple negative breast cancer brain metastases patients after stereotactic radiosurgery and new systemic approaches. Journal of Neuro-Oncology. 168(1). 99–109.
5.
Teitel, Jerome, et al.. (2024). Antisemitism in Medicine: An international Perspective. Rambam Maimonides Medical Journal. 16(1). e0004–e0004. 1 indexed citations
6.
Xiao, Julie, Cheongeun Oh, David Barbee, et al.. (2023). Early effectiveness and toxicity outcomes of reirradiation after breast conserving surgery for recurrent or new primary breast cancer. Breast Cancer Research and Treatment. 198(1). 43–51. 3 indexed citations
7.
Yin, Lu, Elizabeth J. Klein, Daniel Gutiérrez, et al.. (2022). Dermatologist awareness of scalp cooling for chemotherapy-induced alopecia. Journal of the American Academy of Dermatology. 88(1). 176–179. 2 indexed citations
8.
Novik, Yelena, Maryann Kwa, James L. Speyer, et al.. (2020). 129P Phase II study of pembrolizumab and nab-paclitaxel in HER2-negative metastatic breast cancer: Hormone receptor-positive cohort. Annals of Oncology. 31. S59–S59. 2 indexed citations
9.
Kwa, Maryann, Xiaochun Li, Yelena Novik, et al.. (2017). Serial immunological parameters in a phase II trial of exemestane and low-dose oral cyclophosphamide in advanced hormone receptor-positive breast cancer. Breast Cancer Research and Treatment. 168(1). 57–67. 18 indexed citations
10.
Finger, Paul T., et al.. (2016). INTRAVITREAL BEVACIZUMAB IN THE MANAGEMENT OF BREAST CANCER IRIS METASTASIS. Retinal Cases & Brief Reports. 11(1). 47–50. 12 indexed citations
11.
Reynolds, Sandra R., Esteban Celis, Alessandro Sette, et al.. (2000). Identification of HLA-A*03, A*11 and B*07-restricted melanoma-associated peptides that are immunogenic in vivo by vaccine-induced immune response (VIIR) analysis. Journal of Immunological Methods. 244(1-2). 59–67. 22 indexed citations
12.
Rosenthal, Mark, David T. Dennis, Leonard Liebes, et al.. (1998). Biologic Activity of Interleukin 1 (IL-1) Alpha in Patients with Refractory Malignancies. Journal of Immunotherapy. 21(5). 371–378. 4 indexed citations
13.
Reynolds, Sandra R., Esteban Celis, Alessandro Sette, et al.. (1998). HLA-Independent Heterogeneity of CD8+ T Cell Responses to MAGE-3, Melan-A/MART-1, gp100, Tyrosinase, MC1R, and TRP-2 in Vaccine-Treated Melanoma Patients. The Journal of Immunology. 161(12). 6970–6976. 73 indexed citations
14.
Reynolds, Sandra R., Ruth Oratz, Richard L. Shapiro, et al.. (1997). Stimulation of CD8 T cell responses to MAGE‐3 and Melan A/MART‐1 by immunization to a polyvalent melanoma vaccine. International Journal of Cancer. 72(6). 972–976. 3 indexed citations
15.
Reynolds, Sandra R., Ruth Oratz, Richard L. Shapiro, et al.. (1997). Stimulation of CD8+ T cell responses to MAGE-3 and Melan A/MART-1 by immunization to a polyvalent melanoma vaccine. International Journal of Cancer. 72(6). 972–976. 52 indexed citations
16.
Höchster, Howard S., Leonard Liebes, James L. Speyer, et al.. (1997). Effect of prolonged topotecan infusion on topoisomerase 1 levels: a phase I and pharmacodynamic study.. PubMed. 3(8). 1245–52. 49 indexed citations
17.
Oratz, Ruth, Anne Zeleniuch‐Jacquotte, Jian Cui, et al.. (1995). Improved survival of patients with melanoma with an antibody response to immunization to a polyvalent melanoma vaccine. Cancer. 75(2). 495–502. 47 indexed citations
18.
Blum, Ronald H., et al.. (1992). Phase I study of doxorubicin, ICRF-187 and granulocyte/macrophage-colony-stimulating factor. Journal of Cancer Research and Clinical Oncology. 118(1). 61–66. 6 indexed citations
19.
Bystryn, Jean‐Claude, et al.. (1992). Relationship between immune response to melanoma vaccine immunization and clinical outcome in stage II malignant melanoma. Cancer. 69(5). 1157–1164. 78 indexed citations
20.
Bystryn, Jean‐Claude, Ruth Oratz, Matthew N. Harris, et al.. (1988). Immunogenicity of a polyvalent melanoma antigen vaccine in humans. Cancer. 61(6). 1065–1070. 54 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Masahiro Kashiwaba Breakdown of academic impact, for papers by Christina Coughlin Breakdown of academic impact, for papers by Ellen Chuang Breakdown of academic impact, for papers by Mark R. Albertini Breakdown of academic impact, for papers by Dario Sangiolo Breakdown of academic impact, for papers by Danny N. Khalil Breakdown of academic impact, for papers by Gheath Alatrash Breakdown of academic impact, for papers by Cara Haymaker Breakdown of academic impact, for papers by Christoph Höeller Breakdown of academic impact, for papers by S A Cannistra
Rankless by CCL
2026